Company Active LTD

Company profile

Dem DX Limited

Dem Dx Diagnosis Simplified

Dem DX Limited is a UK company with status active founded in 2015.

CRN
09573122
Founded
2015
Age
11

Overview

Legal name
DEM DX LIMITED
Region
Unknown
Registered address
7 CRANE GROVE
LONDON
UNITED KINGDOM
N7 8LB
Insolvency history
No

Company events

Reference milestones and recent Companies House filing stream events.

9 events
31 Jan
2027

Accounts due

Accounts Due

Next accounts due date

18 Jul
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

12 Apr
2026

Termination Director Company With Name Termination Date

Officers

TM01 | Transaction MzUxNTU4Mjg0NmFkaXF6a2N4

Published 12 Apr 2026 11:44

12 Apr
2026

Termination Director Company With Name Termination Date

Officers

TM01 | Transaction MzUxNTU4MjgyNGFkaXF6a2N4

Published 12 Apr 2026 11:43

26 Mar
2026

Capital Allotment Shares

Capital

SH01 | Transaction MzUxMjU3MzAyM2FkaXF6a2N4

Published 26 Mar 2026 16:23

04 Jul
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

30 Apr
2025

Accounts filed

Accounts

Last accounts made up date

08 Oct
2024

Accounts With Accounts Type Unaudited Abridged

Accounts Analysed

AA | Transaction MzQzODcxODgxNGFkaXF6a2N4

Published 08 Oct 2024 10:50

05 May
2015

Incorporated

Inception

Company registered at Companies House

Public funding

10 awards
First funded
2016
Funded years
2016, 2017, 2018, 2020, 2023
Age at first award
0 years

Projects

2023 Collaborative R&D Lead participant

A tailored Care Home Clinical Assessment Tool (CHCAT) for front line clinicians

1 Nov 2023 to 31 Dec 2024

Awarded
£250,095
Total cost £357,279

DemDx will deliver an urgently needed Care Home focused Clinical Assessment Tool (CHCAT). The need is driven by the introduction of the Enhanced Health in Care Homes initiative-aimed at providing a more proactive health service to the elderly and frail care home residents by increasing frontline clinical support to care home nursing staff, community rapid...

2023 Investment Accelerator Lead participant

Community Pharmacy-focused Clinical Assessment Platform (Ph-CAP)

1 May 2023 to 28 Feb 2025

Awarded
£329,613
Total cost £470,876

DemDX will deliver an urgently needed community pharmacy-focused clinical assessment platform (Ph-CAP). The need is driven by the introduction of the Community Pharmacist Consultation Services (CPCS) to integrate community pharmacy into the urgent care and primary care systems by enabling pharmacists to take referrals from NHS 111 and general practice for...

2023 Collaborative R&D Lead participant

AI-Driven Primary Care Clinical Assessment Platform for Allied Health Professionals (PC-CAP)

1 May 2023 to 31 Oct 2024

Awarded
£214,715
Total cost £306,736

NHS Primary Care is in crisis: GP practices are experiencing sharply declining GP numbers (1,565 FTE fewer than 2015) and rising demand (6.1m waiting lists; 30.1m appointments in March 2022). They are struggling to recruit and retain staff (7,000 GP shortfall projected within 5 years). This impacts patient care. The NHS Long Term Plan aims to meet these c...

2020 Collaborative R&D Lead participant

Dem Dx Elderly Care Triage Platform

1 Nov 2020 to 31 May 2021

Awarded
£89,818
Total cost £89,818

**Growing role of Advanced Practitioners in the healthcare workforce** An urgent challenge in the healthcare sector is the increasing demands on global health systems caused by a growing, ageing population and a constrained supply of doctors. The World Health Organisation has called for 6m additional nurses by 2030, from the existing 20m today, to achieve...

2020 CR&D Bilateral Lead participant

Dem Dx Ophthalmology Clinical Platform

1 Oct 2020 to 28 Feb 2021

Awarded
£39,553
Total cost £71,915

Visual impairment affects 285 million people globally with 87% predominantly located in low and middle income countries. The World Health Organisation has stated that providing eye care contributes significantly to economic growth and development by reducing injuries and improving access to education and employment. In Rwanda, with a population of 12.3m, ...

2020 Feasibility Studies Lead participant

Dem Dx Triage Platform (continuity)

1 Jun 2020 to 30 Nov 2020

Awarded
£39,300
Total cost £39,300
2018 Collaborative R&D Lead participant

Dem Dx Triage Platform

1 Nov 2018 to 30 Jun 2020

Awarded
£298,889
Total cost £426,984

* A well recognized challenge in the healthcare sector is the increasing demands on global health systems caused by a growing, ageing population and a constrained supply of doctors. NHS England estimate a financial care gap of £30 billion by 2021 in the UK. * This care gap will partly be filled by allied health professionals (including nurses, occupationa...

2017 EU-Funded Lead participant

Dem Dx Medical Diagnostic Support Tool

1 Dec 2017 to 31 Mar 2018

Awarded
£49,947
Total cost £71,353

Dem Dx is a digital clinical support tool that educates primary healthcare professionals to make more informed clinical decisions. It guides the user from symptom to diagnosis in a step-by-step approach. Dem Dx 's objective is to help reduce missed diagnoses, unnecessary investigations, treatment and referrals, thus relieving the demand and financial burd...

2017 Collaborative R&D Lead participant

Lorin Gresser - Women in Innovation 2016

1 Feb 2017 to 31 Oct 2017

Awarded
£49,800
Total cost £49,800

Dem Dx offers a transparent, step by step, decision making process for healthcare professionals to use in training and when caring for patients. Dem Dx guides the user from the presenting symptoms through to a diagnosis, enabling medical students and clinicians to take a more structured and reasoned approach to clinical care, avoiding unnecessary investig...

2016 GRD Proof of Concept Lead participant

DemDX Proof of Concept

1 Apr 2016 to 31 Mar 2017

Awarded
£100,000
Total cost £166,991

Dem Dx is a supportive decision diagnostic tool aimed at medical students and health care workers, to aid them in differentiating presenting symptoms and suggesting the critical investigations needed to reach a definitive diagnosis. It harnesses the power of a unique medical algorithm, verified by artificial intelligence and decades of clinical experience...

Product types

Collaborative R&D CR&D Bilateral EU-Funded Feasibility Studies GRD Proof of Concept Investment Accelerator